A process for the preparation of substance with potential physiological properties 1,1'-(2"-bromo-2"-chloroethenyl)-bis-(5-nitrouracil) by interaction of known reactants and components of medicinal agents 5-nitrouracil with halothane in molar ratio of 2:1, in the system of solvents (benzene-dimethylformamide) under conditions of phase-transfer catalysis with dibenzo-18-crown-ether.
展开▼